NuVasive — Merger or Acquisition (January 2016)
12 slides from NuVasive's merger presentation, Jan 5, 2016
Slide 1: NuVasive, Inc. Acquisition of Ellipse Technologies, Inc.
NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 Exhibit 99.2
Slide 2: Safe Harbor Statements
Safe Harbor Statements NuVasive, Inc. (“NuVasive,” “NUVA” or the “Company”) cautions you that statements included in this presentation that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not
Slide 3: Ellipse at a Glance
Ellipse at a Glance Committed to innovation, passion for improved clinical outcomes Business Description Privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity Developer and marketer of disruptive, magnetically adjustable implant syst
Slide 4: Strategic rationale for the acquisition
Accelerates NuVasive’s transition from spine implant company to spine solutions company, offering broad range of integrated capabilities to deliver improved clinical and economic outcomes for patients and hospitals Complementary offerings to NuVasive that further diversify revenue mix and present ne
Slide 5: Transaction Overview
Transaction Overview $380mm acquisition with $30mm potential milestone payment, financed with cash on hand Revenue Accelerates revenue growth toward the high single-digit range New applications of existing technology represent further upside opportunity Synergies Near-term annual operating cost syne
Slide 6: Value Proposition
Value Proposition Ellipse’s technology rapidly becoming standard of care in spine and orthopedics Builds on NuVasive’s reputation as leading technology provider and innovator for integrated spine procedure solutions Integrate highly regarded, differentiated and disruptive magnetic growing rod techno
Slide 7: Ellipse's Attractive Growth Profile
Ellipse’s Attractive Growth Profile U.S. dollar amounts in millions, except surgeon count Revenues by Region Revenues by Product U.S. Surgeon Adoption >425% CAGR 2016 revenues expected to be ~$60 million on pro forma basis; Go forward gross margins to range in low to mid ~70%
Slide 8: New, Large Market Opportunities
New, Large Market Opportunities $1.2 billion* current addressable market opportunity Highly scalable business with growth prospects both geographically and in addressable segments Proprietary Technology Non-invasively adjustable implants expected to have significant economic benefits over current im
Slide 9: MAGEC
MAGEC Eliminates lengthening surgeries Fewer complications More frequent adjustment to accommodate growth Improved patient outcomes and quality of life ~$570mm* global market opportunity Rapid training cycle: same initial procedure as traditional rods Single implant: fewer trays, less instrumentatio
Slide 10: PRECICE Revolutionizes Approach
Proprietary PRECICE LLD system developed using MAGEC technology to treat limb length discrepancies Non-invasive, adjustable intramedullary nail coupled with ERC Designed to internally lengthen the long bones of leg with precision and control, and without need for external fixation Innovative techniq
Slide 11: Summary
Reinforces focus on transformative spine solutions to improve patient outcomes Extends position as global spine leader with comprehensive approach to fast-growing complex deformity market Provides new innovation platforms to strategically address broader spine and niche orthopedic applications Immed
Slide 12: Questions & Answers
Questions & Answers J fo